RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Animal Mammary Neoplasms
Accession: DOID:9000403
browse the term
Definition: Tumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL).
Synonyms: exact_synonym: animal mammary neoplasm; mammary neoplasm; mammary neoplasms
narrow_synonym: animal mammary carcinoma; animal mammary carcinomas
primary_id: MESH:D015674
alt_id: RDO:0006059
For additional species annotation, visit the
Alliance of Genome Resources .
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
G
Actb
actin, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
G
Actg1
actin, gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:109,518,429...109,521,288
Ensembl chr 3:75,643,054...75,644,954 Ensembl chr10:75,643,054...75,644,954
G
Actn4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
G
Adcy5
adenylate cyclase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr11:68,695,839...68,842,452
Ensembl chr11:68,695,839...68,842,320
G
Alcam
activated leukocyte cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr11:50,780,735...50,985,083
Ensembl chr11:50,781,127...50,985,083
G
Anxa1
annexin A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942 PMID:22248470
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
G
Anxa2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22248470
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
G
Anxa4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
G
Apc
APC regulator of WNT signaling pathway
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9111214
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
G
Aqp1
aquaporin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
G
Areg
amphiregulin
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18421211
RGD:2292665
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
G
Atp5if1
ATP synthase inhibitory factor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 5:150,719,570...150,723,287
Ensembl chr 5:150,719,569...150,723,321
G
Basp1
brain abundant, membrane attached signal protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:77,586,424...77,632,626
Ensembl chr 2:77,586,424...77,632,628
G
Brca1
BRCA1, DNA repair associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12203372
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
G
Capzb
capping actin protein of muscle Z-line subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:157,642,742...157,742,487
Ensembl chr 5:157,642,751...157,742,478
G
Cask
calcium/calmodulin dependent serine protein kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr X:9,815,652...10,156,155
Ensembl chr X:9,815,652...10,156,155
G
Ccnd1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:14522882 PMID:16316942 PMID:17173897
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Ccnh
cyclin H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:13,593,100...13,613,910
Ensembl chr 2:13,593,100...13,613,910
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:19787232
RGD:6893387
NCBI chr 8:133,026,539...133,040,999
Ensembl chr 8:133,029,625...133,040,997
G
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:15922965
RGD:8547789
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
G
Cdc42
cell division cycle 42
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdk4
cyclin-dependent kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:14522882
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
onset
ISO
RGD
PMID:11103935
RGD:8662404
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
G
Cds1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
G
Cnn3
calponin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:225,005,069...225,036,179
Ensembl chr 2:225,005,019...225,036,188
G
Col5a1
collagen type V alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
G
Comt
catechol-O-methyltransferase
ISO
protein:increased expression:mammary gland, cytoplasm CTD Direct Evidence: marker/mechanism
CTD
PMID:18424824 , PMID:6337293
RGD:2289734
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
G
Coro1a
coronin 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21489049
NCBI chr 1:198,123,883...198,128,890
Ensembl chr 1:198,123,884...198,128,857
G
Csn2
casein beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chr14:21,972,274...21,979,511
Ensembl chr14:21,972,274...21,979,510
G
Csn3
casein kappa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:21,803,738...21,810,291
Ensembl chr14:21,803,735...21,810,314
G
Dbi
diazepam binding inhibitor, acyl-CoA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:36,147,667...36,156,076
Ensembl chr13:36,117,119...36,174,908
G
Des
desmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
G
Dusp6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:113,202,382...113,294,993
Ensembl chr14:113,202,419...113,295,014
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Eif5a
eukaryotic translation initiation factor 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:56,527,075...56,531,615
Ensembl chr10:56,527,085...56,531,483
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
G
Epcam
epithelial cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:11,282,194...11,308,870
Ensembl chr 6:11,281,964...11,298,216
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15637090 PMID:17173897
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Esr2
estrogen receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15637090
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
G
Ezr
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
G
F11r
F11 receptor
ISO
RGD
PMID:21695058
RGD:7488916
NCBI chr13:89,826,272...89,850,151
Ensembl chr13:89,826,254...89,850,612
G
Fabp4
fatty acid binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
G
Fgf2
fibroblast growth factor 2
ISO
RGD
PMID:22407271
RGD:8554853
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
G
Fn1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
G
Furin
furin (paired basic amino acid cleaving enzyme)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:142,185,092...142,198,167
Ensembl chr 1:142,185,094...142,197,182
G
G0s2
G0/G1switch 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
G
Gata3
GATA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
G
Gatm
glycine amidinotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:114,711,570...114,728,155
Ensembl chr 3:114,711,562...114,728,410
G
Gda
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
G
Gnai2
G protein subunit alpha i2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:116,370,730...116,391,337
Ensembl chr 8:116,370,744...116,391,307
G
Gss
glutathione synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557
G
H3f3b
H3.3 histone B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:104,573,666...104,575,890
Ensembl chr10:104,573,664...104,575,890
G
Hba-a2
hemoglobin alpha, adult chain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:15,589,364...15,590,207
Ensembl chr10:15,589,364...15,590,220
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:144,865,302...144,871,592
Ensembl chr 7:144,865,608...144,871,585
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8185828
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
G
Id3
inhibitor of DNA binding 3, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
G
Id4
inhibitor of DNA binding 4, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14633621
NCBI chr17:16,692,557...16,695,126
Ensembl chr17:16,692,557...16,695,126
G
Igf2
insulin-like growth factor 2
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18421211
RGD:2292665
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:44,279,199...44,319,427
Ensembl chr 2:44,289,393...44,314,944
G
Insig1
insulin induced gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
G
Kdr
kinase insert domain receptor
ISO
RGD
PMID:19888452
RGD:5684399
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
G
Kng2
kininogen 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22248470
NCBI chr11:81,509,185...81,516,759
G
Krt5
keratin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:143,320,142...143,324,536
Ensembl chr 7:143,316,920...143,453,546
G
Krt71
keratin 71
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:143,345,201...143,371,346
Ensembl chr 7:143,345,201...143,353,925
G
Lgals7
galectin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:87,044,823...87,047,223
Ensembl chr 1:87,045,335...87,047,223
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:49,429,613...49,627,835
Ensembl chr 7:49,385,705...49,656,856
G
Lpl
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
G
Lsr
lipolysis stimulated lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:89,383,515...89,399,041
Ensembl chr 1:89,383,519...89,399,041
G
Map2k6
mitogen-activated protein kinase kinase 6
ISO
RGD
PMID:17016428
RGD:7495832
NCBI chr10:98,707,160...98,823,054
Ensembl chr10:98,706,960...98,823,287
G
Mdh2
malate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:23,941,451...23,954,406
Ensembl chr12:23,941,448...23,954,431
G
Mgp
matrix Gla protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 4:170,856,783...170,860,105
Ensembl chr 4:170,856,751...170,860,225
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
G
Mir100
microRNA 100
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24447120
NCBI chr 8:45,746,948...45,747,027
Ensembl chr 8:45,746,948...45,747,027
G
Mir10a
microRNA 10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24447120
NCBI chr10:84,165,950...84,166,059
Ensembl chr10:84,165,950...84,166,059
G
Mir10b
microRNA 10b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24447120
NCBI chr 3:61,647,978...61,648,086
Ensembl chr 3:61,647,978...61,648,086
G
Mir145
microRNA 145
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24447120
NCBI chr18:56,969,907...56,969,994
Ensembl chr18:56,969,907...56,969,994
G
Mir205
microRNA 205
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24447120
NCBI chr13:112,233,283...112,233,390
Ensembl chr13:112,233,283...112,233,390
G
Mmp9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:23714264
RGD:8547831
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Mpzl1
myelin protein zero-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:83,805,244...83,842,074
Ensembl chr13:83,805,244...83,842,051
G
Mrc2
mannose receptor, C type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:93,520,272...93,581,599
Ensembl chr10:93,520,132...93,581,296
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Ndn
necdin, MAGE family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21489049
NCBI chr 1:122,981,755...122,983,354
Ensembl chr 1:122,981,755...122,983,351
G
Notch4
notch receptor 4
ISO
DNA, mRNA:mutation, alternative form
RGD
PMID:8030284
RGD:2299155
NCBI chr20:4,329,794...4,353,868
Ensembl chr20:4,329,811...4,353,785
G
Nsmf
NMDA receptor synaptonuclear signaling and neuronal migration factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:2,262,173...2,270,996
Ensembl chr 3:2,262,253...2,270,995
G
Padi4
peptidyl arginine deiminase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:159,260,675...159,293,906
Ensembl chr 5:159,260,675...159,293,673
G
Pdgfa
platelet derived growth factor subunit A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr12:17,734,141...17,756,186
Ensembl chr12:17,734,133...17,755,285
G
Pebp1
phosphatidylethanolamine binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:45,026,948...45,031,148
Ensembl chr12:45,026,886...45,031,145
G
Pgam1
phosphoglycerate mutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:261,158,204...261,165,814
Ensembl chr 1:261,158,261...261,165,808
G
Pgr
progesterone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15637090
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
G
Phb
prohibitin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Pkm
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:64,480,963...64,502,957
Ensembl chr 8:64,481,172...64,502,722
G
Plk2
polo-like kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11137312
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
G
Prdx2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:26,084,816...26,090,095
Ensembl chr19:26,084,903...26,090,094
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6280079 PMID:16316942
NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
G
Prlr
prolactin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942 PMID:17173897
NCBI chr 2:60,131,410...60,325,686
Ensembl chr 2:60,131,776...60,325,692
G
Psma4
proteasome 20S subunit alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:59,532,456...59,539,916
Ensembl chr 8:59,532,389...59,539,920
G
Psme1
proteasome activator subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:34,256,071...34,258,947
Ensembl chr15:34,256,071...34,258,947
G
Ptbp1
polypyrimidine tract binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:12,663,965...12,673,723
Ensembl chr 7:12,663,965...12,673,718
G
Ptger1
prostaglandin E receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11751431
NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
G
Ptn
pleiotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:64,239,156...64,330,996
Ensembl chr 4:64,239,158...64,330,996
G
Ran
RAN, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr12:31,319,556...31,324,105
Ensembl chr12:31,320,624...31,323,810
G
Rasa1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:13,617,021...13,696,531
Ensembl chr 2:13,616,822...13,696,426
G
Rasgrf2
RAS protein-specific guanine nucleotide-releasing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:21,460,041...21,698,937
G
Rassf1
Ras association domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008439
NCBI chr 8:116,307,149...116,318,289
Ensembl chr 8:116,307,141...116,318,289
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14522882 , PMID:21364977
RGD:8547983
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
G
Rbp1
retinol binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 8:106,449,321...106,470,842
Ensembl chr 8:106,449,321...106,470,842
G
Rbp4
retinol binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:256,806,476...256,813,678
Ensembl chr 1:256,806,472...256,813,711
G
Rcn1
reticulocalbin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:95,404,863...95,419,110
Ensembl chr 3:95,406,284...95,418,679
G
Rel
REL proto-oncogene, NF-kB subunit
ISO
RGD
PMID:12897145
RGD:2300264
NCBI chr14:108,490,794...108,517,582
Ensembl chr14:108,491,069...108,509,892
G
Relb
RELB proto-oncogene, NF-kB subunit
ISO
RGD
PMID:12897145
RGD:2300264
NCBI chr 1:80,517,081...80,545,019
Ensembl chr 1:80,517,411...80,544,825
G
Rpl3
ribosomal protein L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:121,297,365...121,302,739
Ensembl chr 7:121,297,355...121,311,565
G
Rpl6
ribosomal protein L6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:40,877,578...40,882,032
Ensembl chr12:40,877,613...40,881,124
G
Rps14
ribosomal protein S14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr18:56,042,532...56,047,316
Ensembl chr18:56,044,369...56,047,316
G
S100a6
S100 calcium binding protein A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:190,007,013...190,008,512
Ensembl chr 2:190,007,216...190,008,511
G
S100a8
S100 calcium binding protein A8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22248470
NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
G
S1pr1
sphingosine-1-phosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:218,654,406...218,658,761
Ensembl chr 2:218,654,554...218,658,761
G
Scarb1
scavenger receptor class B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:36,694,952...36,761,445
Ensembl chr12:36,694,960...36,761,455
G
Scd
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:264,159,966...264,173,061
Ensembl chr 1:264,160,129...264,172,729
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858
G
Sgk1
serum/glucocorticoid regulated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:24,185,451...24,302,309
Ensembl chr 1:24,185,435...24,302,298
G
Slc12a2
solute carrier family 12 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr18:52,917,124...52,985,281
Ensembl chr18:52,917,124...52,985,261
G
Slc25a10
solute carrier family 25 member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:109,665,682...109,674,782
Ensembl chr10:109,665,682...109,673,143
G
Sncg
synuclein, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:10,722,110...10,726,648
Ensembl chr16:10,722,106...10,726,707
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr20:14,080,562...14,095,644
Ensembl chr20:14,080,565...14,095,181
G
Sod1
superoxide dismutase 1
IEP
protein:decreased expression:mammary gland (rat)
RGD
PMID:17157473
RGD:8657018
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
G
Sox9
SRY-box transcription factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379
G
Spint2
serine peptidase inhibitor, Kunitz type, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:87,199,373...87,221,826
Ensembl chr 1:87,199,313...87,221,892
G
Srsf2
serine and arginine rich splicing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:105,792,779...105,795,986
Ensembl chr10:105,792,779...105,795,958
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Stat5a
signal transducer and activator of transcription 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:15609129 PMID:16316942 PMID:17173897 PMID:20235097
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
G
Stmn1
stathmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:152,680,412...152,686,807
Ensembl chr 5:152,680,407...152,686,806
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
G
Tgfa
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490
NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
G
Thrsp
thyroid hormone responsive
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:162,381,251...162,385,575
Ensembl chr 1:162,381,253...162,385,575
G
Tkt
transketolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:6,609,670...6,634,608
Ensembl chr16:6,609,668...6,634,595
G
Tle4
TLE family member 4, transcriptional corepressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:231,394,606...231,531,396
Ensembl chr 1:231,393,379...231,530,786
G
Tmem37
transmembrane protein 37
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21489049
NCBI chr13:36,094,665...36,101,443
Ensembl chr13:36,094,520...36,101,411
G
Tp53i3
tumor protein p53 inducible protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21489049
NCBI chr13:75,101,759...75,145,967
Ensembl chr13:75,105,615...75,143,441
G
Tpm3
tropomyosin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:189,423,534...189,451,340
Ensembl chr 2:189,423,559...189,451,029
G
Trps1
transcriptional repressor GATA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:90,085,895...90,320,430
Ensembl chr 7:90,090,828...90,318,221
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:58,554,358...58,658,156
Ensembl chr15:58,554,374...58,658,153
G
Tubb2b
tubulin, beta 2B class IIb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr17:31,441,640...31,444,687
Ensembl chr17:31,441,630...31,482,759
G
Ube2i
ubiquitin-conjugating enzyme E2I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:14,618,615...14,639,274
Ensembl chr10:14,620,531...14,630,151
G
Ucp2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
G
Vamp8
vesicle-associated membrane protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:100,250,301...100,252,756
Ensembl chr 4:100,250,301...100,252,755
G
Wnt1
Wnt family member 1
ISO
RGD
PMID:10918574
RGD:2298804
NCBI chr 7:140,464,999...140,469,046
Ensembl chr 7:140,464,999...140,469,046
G
Wnt3
Wnt family member 3
ISO
RGD
PMID:10918574
RGD:2298804
NCBI chr10:91,830,709...91,874,907
Ensembl chr10:91,830,654...91,874,793
G
Wnt6
Wnt family member 6
ISO
RGD
PMID:18649356
RGD:2298845
NCBI chr 9:82,033,543...82,047,172
Ensembl chr 9:82,033,543...82,047,166
G
Xdh
xanthine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:75,573,553...75,598,295
Ensembl chr 7:75,574,967...75,597,276
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
RGD
PMID:19654309
RGD:2315553
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14633655 , PMID:19654309
RGD:2315553
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
G
Abcg2
ATP binding cassette subfamily G member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22767648
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
G
Actb
actin, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
G
Actg1
actin, gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:109,518,429...109,521,288
Ensembl chr 3:75,643,054...75,644,954 Ensembl chr10:75,643,054...75,644,954
G
Actn4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
G
Adcy5
adenylate cyclase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr11:68,695,839...68,842,452
Ensembl chr11:68,695,839...68,842,320
G
Adipoq
adiponectin, C1Q and collagen domain containing
disease_progression treatment
ISO IEP
RGD
PMID:19447866 , PMID:22246620
RGD:8694414 , RGD:8694468
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
G
Afp
alpha-fetoprotein
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16322315
NCBI chr14:19,141,755...19,159,919
Ensembl chr14:19,141,755...19,159,923
G
Agt
angiotensinogen
treatment
IDA
RGD
PMID:20837666
RGD:5129167
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
G
Agtr1a
angiotensin II receptor, type 1a
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8389152 , PMID:18421211
RGD:2292665
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
G
Agtr2
angiotensin II receptor, type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8389152
NCBI chr X:119,389,480...119,393,845
Ensembl chr X:119,390,013...119,393,842
G
Akt1
AKT serine/threonine kinase 1
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Akt2
AKT serine/threonine kinase 2
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chr 1:84,400,939...84,451,223
Ensembl chr 1:84,411,726...84,450,162
G
Alcam
activated leukocyte cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr11:50,780,735...50,985,083
Ensembl chr11:50,781,127...50,985,083
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
IEP
mRNA:increased expression:mammary gland tumor (rat)
RGD
PMID:18959458
RGD:2313895
NCBI chr12:6,854,930...6,879,112
Ensembl chr12:6,854,920...6,879,154
G
Antxr1
ANTXR cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:22085271
RGD:9684855
NCBI chr 4:118,946,267...119,131,202
Ensembl chr 4:118,946,268...119,131,202
G
Anxa1
annexin A1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942 , PMID:16316942
RGD:2306898
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
G
Anxa4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
G
Apaf1
apoptotic peptidase activating factor 1
IDA
RGD
PMID:14973070
RGD:2325748
NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
G
Apoe
apolipoprotein E
ISO
RGD
PMID:22469977
RGD:7771597
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
G
Aqp1
aquaporin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
G
Ar
androgen receptor
IEP
RGD
PMID:12150826
RGD:6482679
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
G
Areg
amphiregulin
ISO IEP
protein:increased expression:mammary gland mRNA:increased expression:mammary gland
RGD
PMID:10225449 , PMID:18421211
RGD:2292663 , RGD:2292665
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
G
Atp5if1
ATP synthase inhibitory factor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 5:150,719,570...150,723,287
Ensembl chr 5:150,719,569...150,723,321
G
Aurka
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12124350
NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
G
Bad
BCL2-associated agonist of cell death
treatment severity
IDA IEP
RGD
PMID:23404339 , PMID:20732338
RGD:10053670 , RGD:10053708
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
G
Bak1
BCL2-antagonist/killer 1
ISO
RGD
PMID:19222350
RGD:2315700
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
G
Bard1
BRCA1 associated RING domain 1
ISO
RGD
PMID:18443292
RGD:2293149
NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
G
Basp1
brain abundant, membrane attached signal protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:77,586,424...77,632,626
Ensembl chr 2:77,586,424...77,632,628
G
Bax
BCL2 associated X, apoptosis regulator
treatment severity
IDA IEP
RGD
PMID:23404339 , PMID:20732338
RGD:10053670 , RGD:10053708
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcl2
BCL2, apoptosis regulator
treatment
IDA
RGD
PMID:23404339 , PMID:22668016
RGD:10053670 , RGD:10054128
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l1
Bcl2-like 1
treatment
IDA
RGD
PMID:23404339
RGD:10053670
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Brca1
BRCA1, DNA repair associated
susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12203372 PMID:22767648 , PMID:18443292 , PMID:12203372 , PMID:17505536
RGD:2293149 , RGD:1599502 , RGD:2293155
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
G
Bst2
bone marrow stromal cell antigen 2
disease_progression
ISO
RGD
PMID:23806386 , PMID:23806386
RGD:14398495 , RGD:14398495
NCBI chr16:19,938,781...19,942,353
Ensembl chr16:19,938,784...19,942,353
G
Ca9
carbonic anhydrase 9
IEP
RGD
PMID:17280655
RGD:2293194
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
disease_progression
IEP
protein:increased expression:mammary gland
RGD
PMID:6030068
RGD:2303540
NCBI chr 6:26,657,507...26,680,459
Ensembl chr 6:26,657,780...26,680,284
G
Capzb
capping actin protein of muscle Z-line subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:157,642,742...157,742,487
Ensembl chr 5:157,642,751...157,742,478
G
Cask
calcium/calmodulin dependent serine protein kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr X:9,815,652...10,156,155
Ensembl chr X:9,815,652...10,156,155
G
Casp1
caspase 1
IEP
RGD
PMID:10557324
RGD:2315886
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
G
Casp3
caspase 3
treatment severity
IDA IEP
RGD
PMID:23404339 , PMID:26699876 , PMID:20732338
RGD:10053670 , RGD:13782283 , RGD:10053708
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp7
caspase 7
treatment
IDA ISO
RGD
PMID:23404339 , PMID:26699876 , PMID:23979166
RGD:10053670 , RGD:13782283 , RGD:13209143
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
G
Casp8
caspase 8
severity
IEP
RGD
PMID:20732338
RGD:10053708
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Casp9
caspase 9
treatment severity
IDA IEP ISO
RGD
PMID:17297389 , PMID:26699876 , PMID:20732338 , PMID:20012353
RGD:2315933 , RGD:13782283 , RGD:10053708 , RGD:2315928
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
G
Cav1
caveolin 1
treatment onset
ISO
protein:decreased expression:mammary gland
RGD
PMID:9685399 , PMID:15334058 , PMID:15355971
RGD:2289100 , RGD:8661780 , RGD:2289106
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
G
Ccna2
cyclin A2
ISO
protein:increased expression:mammary gland
RGD
PMID:10713672
RGD:2293347
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
G
Ccnb1
cyclin B1
ISO
RGD
PMID:11146550
RGD:2315939
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
G
Ccnd1
cyclin D1
ISO IEP
CTD Direct Evidence: marker/mechanism protein:decreased expression:mammary gland
CTD
PMID:12376462 PMID:14522882 PMID:16316942 , PMID:17440082 , PMID:12602925 , PMID:12649181
RGD:2296037 , RGD:2289337 , RGD:2289336
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Ccnd3
cyclin D3
IEP ISO
mRNA, protein:increased expression:mammary gland
RGD
PMID:16311245 , PMID:12853979
RGD:2316020 , RGD:2316015
NCBI chr 9:15,404,816...15,410,905
Ensembl chr 9:15,404,822...15,410,943
G
Ccne1
cyclin E1
IEP
protein:decreased expression:mammary gland
RGD
PMID:12649181 , PMID:12602925
RGD:2289336 , RGD:2289337
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
G
Ccnh
cyclin H
IEP ISO
mRNA:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953 , PMID:12606953
RGD:9590264
NCBI chr 2:13,593,100...13,613,910
Ensembl chr 2:13,593,100...13,613,910
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21621198
RGD:6893427
NCBI chr 8:133,026,539...133,040,999
Ensembl chr 8:133,029,625...133,040,997
G
Ccr5
C-C motif chemokine receptor 5
ISO
RGD
PMID:14597737 , PMID:22637726
RGD:8551810 , RGD:8551813
NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614
G
Cd274
CD274 molecule
treatment
IDA
RGD
PMID:29043842
RGD:40886270
NCBI chr 1:247,519,890...247,539,659
Ensembl chr 1:247,519,939...247,537,943
G
Cd40
CD40 molecule
ISO
RGD
PMID:21137078
RGD:8547744
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
G
Cd44
CD44 molecule (Indian blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
G
Cdc25a
cell division cycle 25A
ISO
RGD
PMID:17283130 , PMID:17638870 , PMID:16951165
RGD:2764000 , RGD:2754551 , RGD:2771824
NCBI chr 8:117,953,223...117,971,552
Ensembl chr 8:117,953,444...117,971,519
G
Cdc42
cell division cycle 42
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdh13
cadherin 13
severity
ISO
RGD
PMID:18316604 , PMID:18316604
RGD:2293540 , RGD:2293540
NCBI chr19:50,848,793...51,971,618
Ensembl chr19:50,848,736...51,972,103
G
Cdk2
cyclin dependent kinase 2
ISO
RGD
PMID:16924466
RGD:2293558
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
G
Cdk4
cyclin-dependent kinase 4
susceptibility
IEP ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:14522882 PMID:25221644 , PMID:14522882 , PMID:16413469
RGD:2293581 , RGD:2293577
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
G
Cdk6
cyclin-dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25221644
NCBI chr 4:27,781,728...27,969,653
Ensembl chr 4:27,785,647...27,966,398
G
Cdkl2
cyclin dependent kinase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25333262
NCBI chr14:17,530,170...17,565,950
Ensembl chr14:17,531,398...17,565,950
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
treatment
IEP IDA
protein:increased expression:mammary gland
RGD
PMID:15844214 , PMID:22651929
RGD:2293626 , RGD:10045559
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
disease_progression
ISO IEP
RGD
PMID:18060046 , PMID:20681787
RGD:2289674 , RGD:8552689
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
disease_progression
ISO
RGD
PMID:18060046
RGD:2289674
G
Cdkn2a_v2
cyclin-dependent kinase inhibitor 2A, variant 2
disease_progression
ISO
RGD
PMID:18060046
RGD:2289674
G
Cds1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
G
Clu
clusterin
disease_progression
ISO
RGD
PMID:23099883
RGD:8699504
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
G
Cnn3
calponin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:225,005,069...225,036,179
Ensembl chr 2:225,005,019...225,036,188
G
Col18a1
collagen type XVIII alpha 1 chain
severity
IDA
RGD
PMID:10766159
RGD:70690
NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858
G
Col5a1
collagen type V alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
G
Csf1
colony stimulating factor 1
ISO
RGD
PMID:15205327
RGD:2293710
NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560
G
Csn2
casein beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chr14:21,972,274...21,979,511
Ensembl chr14:21,972,274...21,979,510
G
Csn3
casein kappa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:21,803,738...21,810,291
Ensembl chr14:21,803,735...21,810,314
G
Csnk2a1
casein kinase 2 alpha 1
IEP ISO
RGD
PMID:11827167 , PMID:11827167
RGD:727632 , RGD:727632
NCBI chr 3:147,713,808...147,760,375
Ensembl chr 3:147,713,821...147,757,862
G
Ctnnb1
catenin beta 1
ISO
DNA:missense mutations: :p.S33Y, p.S45F protein:increased expression:mammary gland
RGD
PMID:18060046 , PMID:17510243
RGD:2289674 , RGD:2289816
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
G
Dbi
diazepam binding inhibitor, acyl-CoA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:36,147,667...36,156,076
Ensembl chr13:36,117,119...36,174,908
G
Ddr1
discoidin domain receptor tyrosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr20:3,553,430...3,574,959
Ensembl chr20:3,552,929...3,575,780
G
Des
desmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
G
Dio1
iodothyronine deiodinase 1
IDA
RGD
PMID:11765219
RGD:727335
NCBI chr 5:126,894,837...126,911,532
Ensembl chr 5:126,895,286...126,911,520
G
Dnmt3b
DNA methyltransferase 3 beta
treatment
IEP
RGD
PMID:24447120
RGD:9588304
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
G
Dusp1
dual specificity phosphatase 1
treatment
ISO
RGD
PMID:20837666
RGD:5129167
NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
G
Dusp6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:113,202,382...113,294,993
Ensembl chr14:113,202,419...113,295,014
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2523869 PMID:8603490 , PMID:17203220
RGD:2289979
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Eif5a
eukaryotic translation initiation factor 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:56,527,075...56,531,615
Ensembl chr10:56,527,085...56,531,483
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
G
Epcam
epithelial cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:11,282,194...11,308,870
Ensembl chr 6:11,281,964...11,298,216
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
G
Epo
erythropoietin
treatment
IMP
RGD
PMID:12118093
RGD:11041669
NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
G
Epor
erythropoietin receptor
treatment
IMP
RGD
PMID:12118093
RGD:11041669
NCBI chr 8:22,969,737...22,974,468
Ensembl chr 8:22,969,745...22,974,321
G
Erbb2
erb-b2 receptor tyrosine kinase 2
IDA ISO
Androgen-dependent CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490 PMID:25221644 , PMID:1913683 , PMID:12150826 , PMID:17203220
RGD:2289920 , RGD:6482679 , RGD:2289979
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644
G
Esr1
estrogen receptor 1
susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:epithelial cell, nucleus
CTD
PMID:15637090 , PMID:18055862 , PMID:11759285 , PMID:15637090
RGD:2290019 , RGD:8553057 , RGD:8552983
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Esr2
estrogen receptor 2
treatment
IDA ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:epithelial cell, nucleus
CTD
PMID:15637090 , PMID:24078029 , PMID:15637090
RGD:7364911 , RGD:8552983
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
G
Ezr
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
G
F11r
F11 receptor
ISO
RGD
PMID:22120722
RGD:7488922
NCBI chr13:89,826,272...89,850,151
Ensembl chr13:89,826,254...89,850,612
G
Fabp4
fatty acid binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
G
Fas
Fas cell surface death receptor
ISO
RGD
PMID:18094967
RGD:2290047
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Fbxo10
F-box protein 10
IEP
RGD
PMID:17404222
RGD:1601189
NCBI chr 5:60,589,881...60,636,551
Ensembl chr 5:60,591,023...60,658,564
G
Fgf10
fibroblast growth factor 10
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18421211
RGD:2292665
NCBI chr 2:51,673,480...51,747,533
Ensembl chr 2:51,672,722...51,750,369
G
Fgf7
fibroblast growth factor 7
ISO
RGD
PMID:9000125
RGD:2301094
NCBI chr 3:118,315,859...118,368,464
Ensembl chr 3:118,317,761...118,366,872
G
Fgf8
fibroblast growth factor 8
ISO
RGD
PMID:9840935
RGD:2301098
NCBI chr 1:265,492,949...265,498,965
Ensembl chr 1:265,493,124...265,498,831
G
Flt3
Fms related receptor tyrosine kinase 3
ISO
RGD
PMID:10498246
RGD:2302211
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
G
Fn1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
G
Frmpd1
FERM and PDZ domain containing 1
IEP
RGD
PMID:17404222
RGD:1601189
NCBI chr 5:60,735,413...60,837,773
Ensembl chr 5:60,809,762...60,837,764
G
Furin
furin (paired basic amino acid cleaving enzyme)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:142,185,092...142,198,167
Ensembl chr 1:142,185,094...142,197,182
G
G0s2
G0/G1switch 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
G
Gata3
GATA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
G
Gatm
glycine amidinotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:114,711,570...114,728,155
Ensembl chr 3:114,711,562...114,728,410
G
Gda
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
G
Gh1
growth hormone 1
treatment
IMP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD
PMID:12082019 PMID:15528971 PMID:17584969 , PMID:17584969 , PMID:6139974
RGD:2315650 , RGD:11352806
NCBI chr10:94,486,204...94,488,181
Ensembl chr10:94,486,205...94,488,180
G
Gnai2
G protein subunit alpha i2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:116,370,730...116,391,337
Ensembl chr 8:116,370,744...116,391,307
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
RGD
PMID:28810530
RGD:13792729
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
G
Gsn
gelsolin
IEP
mRNA:decreased expression
RGD
PMID:8895730
RGD:1599869
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
G
Gss
glutathione synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557
G
H19
H19, imprinted maternally expressed transcript (non-protein coding)
IEP
RGD
PMID:15170812
RGD:1642758
NCBI chr 1:215,744,404...215,747,080
G
H2ax
H2A.X variant histone
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
G
H3f3b
H3.3 histone B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:104,573,666...104,575,890
Ensembl chr10:104,573,664...104,575,890
G
Hba-a2
hemoglobin alpha, adult chain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:15,589,364...15,590,207
Ensembl chr10:15,589,364...15,590,220
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IDA
RGD
PMID:17280655
RGD:2293194
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
G
Hmox1
heme oxygenase 1
treatment
IDA ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16319139 , PMID:23215791
RGD:10755708
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:144,865,302...144,871,592
Ensembl chr 7:144,865,608...144,871,585
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15538050
NCBI chr10:34,955,713...34,961,662
Ensembl chr10:34,955,716...34,961,608
G
Hp
haptoglobin
treatment
IDA
RGD
PMID:23880232
RGD:11041861
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
G
Hras
HRas proto-oncogene, GTPase
IAGP ISO
DNA:mutation: :p.G12E (rat) CTD Direct Evidence: marker/mechanism
CTD
PMID:8185828 PMID:11376698 , PMID:19652463
RGD:2314834
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
G
Id1
inhibitor of DNA binding 1, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 3:148,214,623...148,216,715
Ensembl chr 3:148,215,540...148,216,718
G
Id3
inhibitor of DNA binding 3, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
G
Id4
inhibitor of DNA binding 4, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14633621
NCBI chr17:16,692,557...16,695,126
Ensembl chr17:16,692,557...16,695,126
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15217511 PMID:15528971 PMID:17584969 , PMID:23342276
RGD:8549490
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14999141
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il18bp
interleukin 18 binding protein
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr 1:167,091,521...167,095,727
Ensembl chr 1:167,091,522...167,093,560
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:44,279,199...44,319,427
Ensembl chr 2:44,289,393...44,314,944
G
Ilk
integrin-linked kinase
ISO
late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands
RGD
PMID:11704830
RGD:2301733
NCBI chr 1:170,578,941...170,585,192
Ensembl chr 1:170,578,889...170,585,189
G
Insig1
insulin induced gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
G
Itgb3
integrin subunit beta 3
IEP
protein:increased expression:mammary gland:
RGD
PMID:22022542
RGD:8693386
NCBI chr10:92,667,869...92,783,413
Ensembl chr10:92,667,869...92,783,410
G
Kdr
kinase insert domain receptor
IDA ISO
inhibition prevents DMBA-induced atypical ductal hyperplasia and carcinoma in situ
RGD
PMID:15170218 , PMID:19888452
RGD:2291936 , RGD:5684399
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Kit
KIT proto-oncogene receptor tyrosine kinase
IAGP
DNA:mutation (rat)
RGD
PMID:18445266
RGD:2302172
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
G
Krt5
keratin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:143,320,142...143,324,536
Ensembl chr 7:143,316,920...143,453,546
G
Krt7
keratin 7
IEP
RGD
PMID:8570173
RGD:2317439
NCBI chr 7:143,059,731...143,075,907
Ensembl chr 7:143,059,764...143,075,907
G
Krt71
keratin 71
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:143,345,201...143,371,346
Ensembl chr 7:143,345,201...143,353,925
G
Lep
leptin
treatment
IEP
RGD
PMID:22246620
RGD:8694468
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
G
Lgals7
galectin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:87,044,823...87,047,223
Ensembl chr 1:87,045,335...87,047,223
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
IMP
mRNA:splice variant (rat)
RGD
PMID:15044717
RGD:2302177
NCBI chr 6:12,493,182...12,554,482
Ensembl chr 6:12,493,943...12,554,439
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:49,429,613...49,627,835
Ensembl chr 7:49,385,705...49,656,856
G
Lnpep
leucyl and cystinyl aminopeptidase
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD
PMID:16619500 , PMID:16619500
RGD:1582109
NCBI chr 1:59,289,392...59,384,540
Ensembl chr 1:59,297,294...59,347,472 Ensembl chr 1:59,297,294...59,347,472
G
Lpl
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
G
Lsr
lipolysis stimulated lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:89,383,515...89,399,041
Ensembl chr 1:89,383,519...89,399,041
G
Map2k3
mitogen activated protein kinase kinase 3
ISO
RGD
PMID:24233520
RGD:7495808
NCBI chr10:45,089,455...45,110,802
Ensembl chr10:47,182,433...47,203,753
G
Map2k7
mitogen activated protein kinase kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21317887
NCBI chr12:2,546,278...2,555,310
Ensembl chr12:2,548,218...2,555,164
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
RGD
PMID:29435821
RGD:13800872
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:29435821
RGD:13800872
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mdh2
malate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:23,941,451...23,954,406
Ensembl chr12:23,941,448...23,954,431
G
Mgp
matrix Gla protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 4:170,856,783...170,860,105
Ensembl chr 4:170,856,751...170,860,225
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
G
Mir155
microRNA 155
ISO
RGD
PMID:20354188 , PMID:29643534
RGD:21079418 , RGD:21403681
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
G
Mmp1
matrix metallopeptidase 1
treatment
ISO
RGD
PMID:19622769
RGD:8549722
NCBI chr 8:5,703,206...5,723,593
Ensembl chr 8:5,703,206...5,723,591
G
Mmp13
matrix metallopeptidase 13
severity
ISO
RGD
PMID:18698413
RGD:2306081
NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
G
Mmp15
matrix metallopeptidase 15
ISO
mRNA:increased expression:mammary gland
RGD
PMID:15895410
RGD:2314949
NCBI chr19:10,079,881...10,101,380
Ensembl chr19:10,079,765...10,101,451
G
Mmp2
matrix metallopeptidase 2
treatment
IEP ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:28574600 , PMID:19725228 , PMID:23359979
RGD:2325823 , RGD:8657038
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp3
matrix metallopeptidase 3
IMP
RGD
PMID:10428026
RGD:8662909
NCBI chr 8:5,676,608...5,698,579
Ensembl chr 8:5,676,665...5,698,579
G
Mmp7
matrix metallopeptidase 7
onset
ISO
RGD
PMID:9850086
RGD:9685350
NCBI chr 8:5,893,253...5,900,965
Ensembl chr 8:5,893,249...5,901,049
G
Mmp9
matrix metallopeptidase 9
treatment
IEP ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680 , PMID:19725228 , PMID:23359979
RGD:2325823 , RGD:8657038
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Mpzl1
myelin protein zero-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:83,805,244...83,842,074
Ensembl chr13:83,805,244...83,842,051
G
Mrc2
mannose receptor, C type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:93,520,272...93,581,599
Ensembl chr10:93,520,132...93,581,296
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mtor
mechanistic target of rapamycin kinase
IMP
RGD
PMID:22349822
RGD:10040957
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
G
Muc1
mucin 1, cell surface associated
treatment
ISO
RGD
PMID:23015160
RGD:7349374
NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
G
Myc
MYC proto-oncogene, bHLH transcription factor
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
G
Ncoa1
nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21080969
NCBI chr 6:28,677,563...28,931,844
Ensembl chr 6:28,677,540...28,931,843
G
Nfe2l2
nuclear factor, erythroid 2-like 2
treatment
IEP
RGD
PMID:22072621
RGD:10412719
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Notch4
notch receptor 4
ISO
RGD
PMID:15531924
RGD:2299154
NCBI chr20:4,329,794...4,353,868
Ensembl chr20:4,329,811...4,353,785
G
Nsmf
NMDA receptor synaptonuclear signaling and neuronal migration factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:2,262,173...2,270,996
Ensembl chr 3:2,262,253...2,270,995
G
Nudt1
nudix hydrolase 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:12036445
RGD:724605
NCBI chr12:16,391,578...16,398,771
Ensembl chr12:16,391,578...16,395,029
G
Oxt
oxytocin/neurophysin I prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8647655 PMID:15089975
NCBI chr 3:123,106,694...123,107,534
Ensembl chr 3:123,106,694...123,107,534
G
Padi4
peptidyl arginine deiminase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:159,260,675...159,293,906
Ensembl chr 5:159,260,675...159,293,673
G
Pak4
p21 (RAC1) activated kinase 4
ISO
RGD
PMID:20697354
RGD:7775027
NCBI chr 1:85,162,462...85,201,746
Ensembl chr 1:85,162,452...85,201,757
G
Parp1
poly (ADP-ribose) polymerase 1
treatment
IDA
RGD
PMID:23404339
RGD:10053670
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Pcna
proliferating cell nuclear antigen
IEP
mRNA,protein:increased expression:mammary gland:
RGD
PMID:2567593
RGD:10448972
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
G
Pcp4
Purkinje cell protein 4
IEP
mRNA,protein:increased expression:cytoplasm:
RGD
PMID:19480007
RGD:9850273
NCBI chr11:36,851,035...36,912,272
Ensembl chr11:36,851,038...36,912,229
G
Pdgfa
platelet derived growth factor subunit A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr12:17,734,141...17,756,186
Ensembl chr12:17,734,133...17,755,285
G
Pebp1
phosphatidylethanolamine binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:45,026,948...45,031,148
Ensembl chr12:45,026,886...45,031,145
G
Pgam1
phosphoglycerate mutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:261,158,204...261,165,814
Ensembl chr 1:261,158,261...261,165,808
G
Pgr
progesterone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15637090
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
G
Phb
prohibitin
IEP ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 , PMID:12376462
RGD:2292404
NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Pin1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
IEP
RGD
PMID:22064478
RGD:8693420
NCBI chr 8:21,669,236...21,680,615
Ensembl chr 8:21,669,236...21,680,615
G
Pkm
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:64,480,963...64,502,957
Ensembl chr 8:64,481,172...64,502,722
G
Plau
plasminogen activator, urokinase
disease_progression
IMP
RGD
PMID:18052026
RGD:6484140
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
G
Plk2
polo-like kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11137312
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
G
Prdx2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:26,084,816...26,090,095
Ensembl chr19:26,084,903...26,090,094
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
G
Prlr
prolactin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:60,131,410...60,325,686
Ensembl chr 2:60,131,776...60,325,692
G
Psma4
proteasome 20S subunit alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:59,532,456...59,539,916
Ensembl chr 8:59,532,389...59,539,920
G
Psme1
proteasome activator subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:34,256,071...34,258,947
Ensembl chr15:34,256,071...34,258,947
G
Ptbp1
polypyrimidine tract binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:12,663,965...12,673,723
Ensembl chr 7:12,663,965...12,673,718
G
Pten
phosphatase and tensin homolog
onset
ISO
RGD
PMID:18381417
RGD:2292496
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
G
Ptger1
prostaglandin E receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11751431
NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP ISO IMP
mRNA:increased expression:breast
RGD
PMID:21623034 , PMID:18676768 , PMID:18279516
RGD:5135030 , RGD:2300118 , RGD:2300130
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Ptk2
protein tyrosine kinase 2
disease_progression
ISO IMP
CTD Direct Evidence: therapeutic
CTD
PMID:24809783 , PMID:18056629 , PMID:15930288
RGD:2292554 , RGD:2292560
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
G
Ptn
pleiotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:64,239,156...64,330,996
Ensembl chr 4:64,239,158...64,330,996
G
Ran
RAN, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr12:31,319,556...31,324,105
Ensembl chr12:31,320,624...31,323,810
G
Rasa1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:13,617,021...13,696,531
Ensembl chr 2:13,616,822...13,696,426
G
Rasgrf2
RAS protein-specific guanine nucleotide-releasing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:21,460,041...21,698,937
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14522882
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
G
Rbp1
retinol binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 8:106,449,321...106,470,842
Ensembl chr 8:106,449,321...106,470,842
G
Rbp4
retinol binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:256,806,476...256,813,678
Ensembl chr 1:256,806,472...256,813,711
G
Rcn1
reticulocalbin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:95,404,863...95,419,110
Ensembl chr 3:95,406,284...95,418,679
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
protein:decreased expression:peritoneal macrophage
RGD
PMID:16288051
RGD:2298764
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Relb
RELB proto-oncogene, NF-kB subunit
ISO
RGD
PMID:16260626
RGD:7777148
NCBI chr 1:80,517,081...80,545,019
Ensembl chr 1:80,517,411...80,544,825
G
Rnpep
arginyl aminopeptidase
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD
PMID:16619500 , PMID:16619500
RGD:1582109
NCBI chr13:52,092,863...52,124,006
Ensembl chr13:52,092,859...52,111,363
G
Rpl3
ribosomal protein L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:121,297,365...121,302,739
Ensembl chr 7:121,297,355...121,311,565
G
Rpl6
ribosomal protein L6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:40,877,578...40,882,032
Ensembl chr12:40,877,613...40,881,124
G
Rps14
ribosomal protein S14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr18:56,042,532...56,047,316
Ensembl chr18:56,044,369...56,047,316
G
Rxra
retinoid X receptor alpha
IMP
RGD
PMID:16344269
RGD:1643109
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
G
S100a6
S100 calcium binding protein A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:190,007,013...190,008,512
Ensembl chr 2:190,007,216...190,008,511
G
S1pr1
sphingosine-1-phosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:218,654,406...218,658,761
Ensembl chr 2:218,654,554...218,658,761
G
Scarb1
scavenger receptor class B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:36,694,952...36,761,445
Ensembl chr12:36,694,960...36,761,455
G
Scd
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:264,159,966...264,173,061
Ensembl chr 1:264,160,129...264,172,729
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858
G
Sgk1
serum/glucocorticoid regulated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:24,185,451...24,302,309
Ensembl chr 1:24,185,435...24,302,298
G
Slc12a2
solute carrier family 12 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr18:52,917,124...52,985,281
Ensembl chr18:52,917,124...52,985,261
G
Slc25a10
solute carrier family 25 member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:109,665,682...109,674,782
Ensembl chr10:109,665,682...109,673,143
G
Sncg
synuclein, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:10,722,110...10,726,648
Ensembl chr16:10,722,106...10,726,707
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr20:14,080,562...14,095,644
Ensembl chr20:14,080,565...14,095,181
G
Socs1
suppressor of cytokine signaling 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452 , PMID:20354188
RGD:2298899 , RGD:21079418
NCBI chr10:4,956,795...4,958,472
Ensembl chr10:4,957,326...4,958,461
G
Socs3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452
RGD:2298899
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23964924
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
G
Sox9
SRY-box transcription factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379
G
Spint2
serine peptidase inhibitor, Kunitz type, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:87,199,373...87,221,826
Ensembl chr 1:87,199,313...87,221,892
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15318939
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
G
Srsf2
serine and arginine rich splicing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:105,792,779...105,795,986
Ensembl chr10:105,792,779...105,795,958
G
Stat1
signal transducer and activator of transcription 1
ISO
RGD
PMID:11325527
RGD:2291895
NCBI chr 9:54,287,540...54,327,958
Ensembl chr 9:54,287,541...54,484,533
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942 , PMID:17483332
RGD:2291914
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Stat5a
signal transducer and activator of transcription 5A
susceptibility
IEP ISO
protein:increased tyrosine phosphorylation:mammary gland CTD Direct Evidence: marker/mechanism protein:altered localization:nucleus
CTD
PMID:12376462 PMID:15609129 PMID:16316942 , PMID:17173897 , PMID:15609129 , PMID:12082622
RGD:2291927 , RGD:2291932 , RGD:2298539
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
G
Stat6
signal transducer and activator of transcription 6
ISO
RGD
PMID:11086031
RGD:2298563
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
G
Stc2
stanniocalcin 2
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr10:16,542,909...16,552,675
Ensembl chr10:16,542,882...16,553,295
G
Stmn1
stathmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:152,680,412...152,686,807
Ensembl chr 5:152,680,407...152,686,806
G
Tdg
thymine-DNA glycosylase
ISO
mRNA:increased expression:mammary gland tumor (mouse)
RGD
PMID:9794235
RGD:2317355
NCBI chr 7:27,194,000...27,213,676
Ensembl chr 7:27,193,998...27,214,236
G
Terc
telomerase RNA component
ISO
RNA:increased expression:mammary gland
RGD
PMID:9857231
RGD:2291975
NCBI chr 2:116,432,723...116,433,110
Ensembl chr 2:116,432,691...116,433,110
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
G
Tff1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr20:9,892,124...9,895,984
Ensembl chr20:9,892,124...9,895,984
G
Tgfa
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490
NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
G
Tgfb1
transforming growth factor, beta 1
ISO
RGD
PMID:8466857
RGD:7394797
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
G
Tgfbr1
transforming growth factor, beta receptor 1
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr 5:63,056,071...63,119,635
Ensembl chr 5:63,050,758...63,119,635
G
Tgfbr2
transforming growth factor, beta receptor 2
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494
G
Thbs1
thrombospondin 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:15459484
RGD:1626167
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
G
Thrsp
thyroid hormone responsive
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:162,381,251...162,385,575
Ensembl chr 1:162,381,253...162,385,575
G
Tkt
transketolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:6,609,670...6,634,608
Ensembl chr16:6,609,668...6,634,595
G
Tle4
TLE family member 4, transcriptional corepressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:231,394,606...231,531,396
Ensembl chr 1:231,393,379...231,530,786
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:19755514
RGD:7401185
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnfrsf10b
TNF receptor superfamily member 10b
ISO
RGD
PMID:17671220
RGD:2290495
NCBI chr15:51,433,853...51,464,215
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21252285
NCBI chr 2:113,008,008...113,026,899
Ensembl chr 2:113,007,549...113,026,899
G
Tp53
tumor protein p53
disease_progression
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24809783 , PMID:17470299 , PMID:18092324
RGD:2290577 , RGD:2290539
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tpm3
tropomyosin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:189,423,534...189,451,340
Ensembl chr 2:189,423,559...189,451,029
G
Trps1
transcriptional repressor GATA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:90,085,895...90,320,430
Ensembl chr 7:90,090,828...90,318,221
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:58,554,358...58,658,156
Ensembl chr15:58,554,374...58,658,153
G
Tubb2b
tubulin, beta 2B class IIb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr17:31,441,640...31,444,687
Ensembl chr17:31,441,630...31,482,759
G
Txnip
thioredoxin interacting protein
severity
IEP
mRNA:decreased expression:mammary gland
RGD
PMID:15170812
RGD:1642758
NCBI chr 2:198,683,168...198,686,971
Ensembl chr 2:198,683,159...198,686,974
G
Tyms
thymidylate synthetase
IMP
RGD
PMID:9635926
RGD:2315839
NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
G
Ube2i
ubiquitin-conjugating enzyme E2I
ISO
MCF-7 human breast cancer cell tumors grown in nude mice CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942 , PMID:15735760
RGD:2301345
NCBI chr10:14,618,615...14,639,274
Ensembl chr10:14,620,531...14,630,151
G
Ucp2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
G
Vamp8
vesicle-associated membrane protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:100,250,301...100,252,756
Ensembl chr 4:100,250,301...100,252,755
G
Vdr
vitamin D receptor
ISO
RGD
PMID:15333467
RGD:8158073
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Wnt1
Wnt family member 1
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 7:140,464,999...140,469,046
Ensembl chr 7:140,464,999...140,469,046
G
Wnt2
Wnt family member 2
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:45,286,845...45,332,899
Ensembl chr 4:45,292,437...45,332,420
G
Wnt3
Wnt family member 3
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:9419423
RGD:2298848
NCBI chr10:91,830,709...91,874,907
Ensembl chr10:91,830,654...91,874,793
G
Wnt3a
Wnt family member 3A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:9419423 , PMID:8065359
RGD:2298848 , RGD:2298863
NCBI chr10:45,598,898...45,643,151
Ensembl chr10:45,598,912...45,638,035
G
Wnt5b
Wnt family member 5B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:151,500,962...151,516,894
Ensembl chr 4:151,500,957...151,516,894
G
Wnt6
Wnt family member 6
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 9:82,033,543...82,047,172
Ensembl chr 9:82,033,543...82,047,166
G
Wnt7a
Wnt family member 7A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:122,994,425...123,040,609
Ensembl chr 4:122,994,425...123,040,609
G
Wnt7b
Wnt family member 7B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 7:126,423,418...126,465,724
Ensembl chr 7:126,420,656...126,465,723
G
Xdh
xanthine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
G
Xiap
X-linked inhibitor of apoptosis
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12766084
NCBI chr X:128,409,425...128,455,786
Ensembl chr X:128,409,472...128,453,000
G
Xrcc3
X-ray repair cross complementing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 6:136,366,917...136,380,751
Ensembl chr 6:136,371,555...136,379,348
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:75,573,553...75,598,295
Ensembl chr 7:75,574,967...75,597,276
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all